Total Payments
$751,361
2024 Payments
$3,547
Companies
39
Transactions
1,469
Medicare Patients
14,162
Medicare Billing
$7.0M
Payment Breakdown by Category
Other$435,498 (58.0%)
Consulting$187,740 (25.0%)
Travel$92,006 (12.2%)
Food & Beverage$31,963 (4.3%)
Research$3,935 (0.5%)
Education$218.55 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $424,548 | 232 | 56.5% |
| Consulting Fee | $187,740 | 46 | 25.0% |
| Travel and Lodging | $92,006 | 234 | 12.2% |
| Food and Beverage | $31,963 | 940 | 4.3% |
| Honoraria | $10,950 | 4 | 1.5% |
| Unspecified | $3,935 | 2 | 0.5% |
| Education | $218.55 | 11 | 0.0% |
Payments by Type
General
$747,426
1,467 transactions
Research
$3,935
1 transactions
Ownership
$0
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $280,128 | 435 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $83,361 | 191 | $0 (2024) |
| United Rheumatology | $78,573 | 9 | $0 (2021) |
| Lilly USA, LLC | $59,662 | 109 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $51,862 | 70 | $0 (2020) |
| PFIZER INC. | $47,993 | 126 | $0 (2024) |
| Radius Health, Inc. | $39,743 | 62 | $0 (2024) |
| Genentech USA, Inc. | $32,898 | 85 | $0 (2024) |
| Eli Lilly and Company | $25,036 | 8 | $0 (2019) |
| UCB, Inc. | $15,089 | 51 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,547 | 87 | Amgen Inc. ($1,233) |
| 2023 | $12,749 | 88 | PFIZER INC. ($6,893) |
| 2022 | $41,885 | 98 | Amgen Inc. ($31,540) |
| 2021 | $36,796 | 38 | Amgen Inc. ($23,737) |
| 2020 | $98,190 | 111 | Amgen Inc. ($44,887) |
| 2019 | $189,309 | 371 | Amgen Inc. ($74,699) |
| 2018 | $196,485 | 352 | Amgen Inc. ($45,541) |
| 2017 | $172,400 | 324 | Amgen Inc. ($54,595) |
All Payment Transactions
1,469 individual payment records from CMS Open Payments — Page 1 of 59
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $27.96 | General |
| Category: Immunology | ||||||
| 11/21/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.10 | General |
| Category: Immunology | ||||||
| 11/16/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $137.40 | General |
| Category: Dermatology | ||||||
| 11/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $123.59 | General |
| Category: Immunology | ||||||
| 11/16/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $75.12 | General |
| 11/16/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $71.72 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 11/16/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $33.13 | General |
| Category: Dermatology | ||||||
| 11/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: Immunology | ||||||
| 11/15/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $127.94 | General |
| Category: Bone Health | ||||||
| 11/06/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $130.74 | General |
| 11/06/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $29.89 | General |
| Category: Inflammation | ||||||
| 10/31/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $26.72 | General |
| Category: Immunology | ||||||
| 10/31/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 10/31/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $3.06 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 10/23/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $23.27 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Dermatology | ||||||
| 10/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $123.37 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2024 | GENZYME CORPORATION | KEVZARA (Biological) | Food and Beverage | In-kind items and services | $20.62 | General |
| Category: Rheumatology | ||||||
| 10/03/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $24.74 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 09/26/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $33.13 | General |
| Category: Dermatology | ||||||
| 09/23/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $12.67 | General |
| Category: Dermatology | ||||||
| 09/19/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Medical management patterns following non-traumatic fracture in US post-menopausal women | Amgen Inc. | $3,935 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 41 | 2,962 | 124,658 | $4.7M | $1.5M |
| 2022 | 48 | 3,838 | 112,855 | $4.9M | $1.6M |
| 2021 | 51 | 3,567 | 104,767 | $4.9M | $1.9M |
| 2020 | 46 | 3,795 | 124,160 | $4.9M | $2.0M |
Total Patients
14,162
Total Services
466,440
Medicare Billing
$7.0M
Procedure Codes
186
All Medicare Procedures & Services
186 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 155 | 15,840 | $665,280 | $290,655 | 43.7% |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 48 | 8,575 | $600,250 | $287,497 | 47.9% |
| J3111 | Injection, romosozumab-aqqg, 1 mg | Office | 2023 | 27 | 31,920 | $798,000 | $251,325 | 31.5% |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Office | 2023 | 53 | 6,876 | $807,360 | $179,477 | 22.2% |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 11 | 37,600 | $526,400 | $146,269 | 27.8% |
| J9312 | Injection, rituximab, 10 mg | Office | 2023 | 11 | 1,550 | $232,500 | $90,148 | 38.8% |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | Office | 2023 | 22 | 5,700 | $285,000 | $59,919 | 21.0% |
| J3262 | Injection, tocilizumab, 1 mg | Office | 2023 | 13 | 12,200 | $134,200 | $56,717 | 42.3% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 181 | 749 | $131,075 | $41,073 | 31.3% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 161 | 347 | $124,920 | $34,120 | 27.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 375 | 511 | $91,469 | $31,580 | 34.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 149 | 177 | $44,250 | $14,677 | 33.2% |
| 77085 | Dxa bone density measurement of hip, pelvis, spine including spine fracture assessment | Office | 2023 | 164 | 166 | $41,500 | $8,209 | 19.8% |
| 77089 | Calculation of trabecular bone score (tbs) using imaging data with interpretation and report on fracture risk | Office | 2023 | 183 | 186 | $21,762 | $5,166 | 23.7% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 51 | 192 | $24,000 | $4,078 | 17.0% |
| 76881 | Complete ultrasound scan of joint | Office | 2023 | 50 | 92 | $22,080 | $3,413 | 15.5% |
| 86481 | Tuberculosis test, enumeration of t-cells | Office | 2023 | 33 | 33 | $10,824 | $3,234 | 29.9% |
| 82306 | Vitamin d-3 level | Office | 2023 | 97 | 102 | $16,218 | $2,959 | 18.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 233 | 377 | $14,326 | $2,869 | 20.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 243 | 314 | $7,850 | $2,638 | 33.6% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 30 | 34 | $7,446 | $1,637 | 22.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $3,990 | $1,499 | 37.6% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 32 | 35 | $8,330 | $1,416 | 17.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 115 | 128 | $6,400 | $1,325 | 20.7% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 25 | 25 | $5,950 | $1,209 | 20.3% |
About Dr. Andrew Laster, MD
Dr. Andrew Laster, MD is a Rheumatology healthcare provider based in Charlotte, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1669428488.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andrew Laster, MD has received a total of $751,361 in payments from pharmaceutical and medical device companies, with $3,547 received in 2024. These payments were reported across 1,469 transactions from 39 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($424,548).
As a Medicare-enrolled provider, Laster has provided services to 14,162 Medicare beneficiaries, totaling 466,440 services with total Medicare billing of $7.0M. Data is available for 4 years (2020–2023), covering 186 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Location Charlotte, NC
- Active Since 05/25/2006
- Last Updated 10/25/2023
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1669428488
Products in Payments
- Prolia (Biological) $129,824
- EVENITY (Biological) $92,872
- COSENTYX (Biological) $64,025
- KEVZARA SARILUMAB INJECTION (Biological) $47,962
- XELJANZ (Drug) $46,231
- Tymlos (Biological) $38,481
- OLUMIANT (Drug) $21,888
- Actemra (Biological) $17,617
- KEVZARA (Biological) $17,402
- Tavneos (Drug) $15,551
- Rituxan (Biological) $15,231
- Cimzia (Drug) $15,034
- TALTZ (Drug) $7,143
- KEVZARA (Drug) $4,299
- TAVNEOS (Drug) $3,972
- INFLECTRA (Biological) $1,624
- ORENCIA (Biological) $1,268
- COSENTYX (Drug) $1,075
- Enbrel (Biological) $1,072
- SAPHNELO (Biological) $566.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Charlotte
Gordon Lam, Md, MD
Rheumatology — Payments: $3.1M
Rheumatology $3.1M
Dr. Heather Gladue, Do, DO
Rheumatology — Payments: $207,205
Rheumatology $207,205
Firas Kassab, M.d, M.D
Rheumatology — Payments: $71,224
Rheumatology $71,224
Dr. Alireza Nami, M.d, M.D
Rheumatology — Payments: $56,705
Rheumatology $56,705
John Brendese, M.d., Facr, M.D., FACR
Rheumatology — Payments: $21,513
Rheumatology $21,513
Dr. Ashley Toci, M.d, M.D
Rheumatology — Payments: $8,229
Rheumatology $8,229